Dataset Information


Induction of autophagy and autophagy-dependent apoptosis in diffuse large B-cell lymphoma by a new antimalarial artemisinin derivative, SM1044.

ABSTRACT: Diffuse large B-cell lymphoma (DLBCL) is the most common form of non-Hodgkin's lymphoma. R-CHOP is currently the standard therapy for DLBCL, but the prognosis of refractory or recurrent patients remains poor. In this study, we synthesized a new water-soluble antimalarial drug artemisinin derivative, SM1044. The treatment of DLBCL cell lines with SM1044 induces autophagy-dependent apoptosis, which is directed by an accelerated degradation of the antiapoptosis protein Survivin, via its acetylation-dependent interaction with the autophagy-related protein LC3-II. Additionally, SM1044 also stimulates the de novo synthesis of ceramide, which in turn activates the CaMKK2-AMPK-ULK1 axis, leading to the initiation of autophagy. Our findings not only elucidate the mechanism of autophagy-dependent apoptosis in DLBCL cells, but also suggest that SM1044 is a promising therapeutic molecule for the treatment of DLBCL, along with R-CHOP regimen.


PROVIDER: S-EPMC5806110 | BioStudies | 2018-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2012-01-01 | S-EPMC3290566 | BioStudies
2014-01-01 | S-EPMC4294376 | BioStudies
2014-01-01 | S-EPMC4269832 | BioStudies
1000-01-01 | S-EPMC4590592 | BioStudies
1000-01-01 | S-EPMC5090708 | BioStudies
1000-01-01 | S-EPMC4590606 | BioStudies
2019-01-01 | S-EPMC6928684 | BioStudies
2019-01-01 | S-EPMC6742667 | BioStudies
2016-01-01 | S-EPMC5166502 | BioStudies
2020-01-01 | S-EPMC7145817 | BioStudies